Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Incidence and Risk Factors Associated with Fatal Graft Vs Host Disease after Solid Organ Transplantation in United Network of Organ Transplant Database

Pavan Tenneti, Jiaxian He, Peter Lalli, Pranav Tenneti, Michael R. Grunwald, Edward A. Copelan, Belinda Avalos, Srinivasa Reddy R. Sanikommu

Blood (2021) 138 (Supplement 1): 4067.

https://doi.org/10.1182/blood-2021-154104

Published: 2021

Journal Articles

Acute Myeloid Leukemia Patients in Complete Remission with Positive Measurable Residual Disease Prior to Allogeneic Transplant Have Worse Outcomes, Similar to Active Disease Regardless of Conditioning Regimen Intensity and Post-Transplant Cyclophosphamide Administration

Pavan Tenneti, Jiaxian He, Brittany Knick Ragon, Nilay A. Shah, Jing Ai, Aleksander L. Chojecki, Thomas G. Knight, Belinda Avalos, Edward A. Copelan, Michael R. Grunwald, Srinivasa Reddy R. Sanikommu

Blood (2021) 138 (Supplement 1): 4907.

https://doi.org/10.1182/blood-2021-154011

Published: 2021

Journal Articles

Novel Combination Drug Regimens Using Hypomethylating Agents in Treatment of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Pavan Tenneti, MD, Zabih Warraich, MD, Ankith Tenneti, Srinivasa R. Sanikommu, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-143398

Published: 2020

Journal Articles

The Healthcare Burden of Emergency Department Utilization for Multiple Myeloma: A Five Years U.S. Nationwide Study

Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Pavan Tenneti, MD, Rehan Farooqi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3562.

https://doi.org/10.1182/blood-2018-99-119932

Published: 2018

Journal Articles

Survival Benefit of Novel Drug Combinations Using Hypomethylating Agents for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Systemic Review

Pavan Tenneti, MD, Keri R Maher, DO, Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Saad Ullah Malik, MD, Warda Faridi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5182.

https://doi.org/10.1182/blood-2018-99-115810

Published: 2018

Journal Articles

National Trends in Leukemia Related Emergency Department Visits, Health Care Burden and Disposition Rate in the United States, 2010-2014

Mohamed Mokhtar Bakr, MD, Umar Zahid, MD MPH, Pavan Tenneti, MD, Alsadiq Waleed Al-Hillan, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 4695.

https://doi.org/10.1182/blood-2018-99-117879

Published: 2018

Journal Articles

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

Pavan Tenneti, MD, Umar Zahid, MD, Ahmad Iftikhar, MD, Seongseok Yun, MD PhD, Vikas Kapoor, MD, Azka Latif, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 2014.

https://doi.org/10.1182/blood.V130.Suppl_1.2014.2014

Published: 2017

Journal Articles

Precision Therapy Targeting Signal Transduction Aberrant Pathways in Multiple Myeloma

Raahem Nayab Zafar, BS, Atlantis Dawn Russ, MD PhD, Ahmad Iftikhar, MD, Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Pavan Tenneti, MD, Mirza Zeeshan Baig, MD, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5403.

https://doi.org/10.1182/blood.V130.Suppl_1.5403.5403

Published: 2017

Journal Articles

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Azka Latif, MD, Vikas Kapoor, MD, Faisal Akbar, MD, Ali McBride, PharmD,MS, Ahmad Iftikhar, MD, Pavan Tenneti, MD, Adeela Mushtaq, MD, Raahem Nayab Zafar, BS, Hafiz Muhammad Fazeel, MD, Syeda Sabeeka Batool, MBBS, Zabih Warraich, MD, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5411.

https://doi.org/10.1182/blood.V130.Suppl_1.5411.5411

Published: 2017

Journal Articles

Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review

Adeela Mushtaq, MD, Azka Latif, MD, Vikas Kapoor, MD, Faiza Hassan Warraich, MD, Sami Ullah Warraich, MBBS, Ahmad Iftikhar, MD, Pavan Tenneti, MD, Raahem Nayab Zafar, BS, Atlantis Dawn Russ, MD PhD, Ivo Abraham, PhD RN, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2017) 130 (Supplement 1): 5413.

https://doi.org/10.1182/blood.V130.Suppl_1.5413.5413

Published: 2017

NARROW

Incidence and Risk Factors Associated with Fatal Graft Vs Host Disease after Solid Organ Transplantation in United Network of Organ Transplant Database

Acute Myeloid Leukemia Patients in Complete Remission with Positive Measurable Residual Disease Prior to Allogeneic Transplant Have Worse Outcomes, Similar to Active Disease Regardless of Conditioning Regimen Intensity and Post-Transplant Cyclophosphamide Administration

Novel Combination Drug Regimens Using Hypomethylating Agents in Treatment of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

The Healthcare Burden of Emergency Department Utilization for Multiple Myeloma: A Five Years U.S. Nationwide Study

Survival Benefit of Novel Drug Combinations Using Hypomethylating Agents for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Systemic Review

National Trends in Leukemia Related Emergency Department Visits, Health Care Burden and Disposition Rate in the United States, 2010-2014

Role of High Dose Chemotherapy and Autologous Stem Cell Transplant in Relapsed Ewing's Sarcoma — a Systematic Review

Precision Therapy Targeting Signal Transduction Aberrant Pathways in Multiple Myeloma

Emerging Clinical Concepts for Personalized Therapy in Multiple Myeloma; Systemtic Review

Efficacy and Toxicity Profile of Carfilzomib Based Regimens for Treatment of Multiple Myeloma, a Systematic Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only